How Did a Stress-Management Trial Protocol Handle Medication Changes?

When a study evaluates psychological treatment, medication changes can complicate attribution of improvement. The 2017 Seren@ctif protocol described how investigators planned to address this issue in a trial of adjustment disorder with anxiety.

The planned comparison

Servant and colleagues proposed three randomized groups receiving computer-based stress management, an equivalent face-to-face program, or a waiting-list condition with usual medical care. The primary outcome was planned change in the trait anxiety scale at two months, with further assessments at six months.

The computer program comprised five weekly sessions and brief nurse contact before and after each session. That contact included questions about adverse events and drug-dose changes, as well as assistance with participation.

Stable treatment was part of eligibility

Participants were to have no new psychotropic treatment or a regimen stable for at least three months. For those taking established treatment, the protocol called for maintaining the same doses during the study. Starting a new medication or changing medication doses was also listed among circumstances for ending participation at the investigator’s direction.

Those choices aimed to make changes in anxiety easier to interpret, while narrowing the clinical circumstances represented by the study. Patients undergoing active medication adjustment could differ from those eligible for this design.

What this publication establishes

This article is a protocol. Its proposed measurements of anxiety, satisfaction, and substance consumption do not establish that the planned interventions achieved those outcomes. Feasibility observations mentioned in the paper concern a different evidentiary question from the controlled efficacy comparison.

For attorneys evaluating a claimed treatment effect, compare the actual medication timeline with the study’s eligibility and follow-up rules. A protocol can document how investigators intended to address competing explanations. Observed effectiveness requires the corresponding results and their handling of withdrawals and missing data.

Source

Servant D and colleagues. Efficacy of Seren@ctif, a Computer-Based Stress Management Program for Patients With Adjustment Disorder With Anxiety. JMIR Research Protocols, 2017. Full text · DOI 10.2196/resprot.7976.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

How Did a Laboratory Study Decide That a Detected Drug Was Non-Prescribed?

A laboratory can identify a drug while relying on outside information to classify its prescription status. A national urine-testing study combined analytical results with medication information supplied by the ordering clinician. Two information streams McClure and colleagues analyzed 231,228 test-result sets from 144,535 patients tested for both opioids and benzodiazepines….

Spread the love

Read Article: How Did a Laboratory Study Decide That a Detected Drug Was Non-Prescribed?

How Did a Stress-Management Trial Protocol Handle Medication Changes?

When a study evaluates psychological treatment, medication changes can complicate attribution of improvement. The 2017 Seren@ctif protocol described how investigators planned to address this issue in a trial of adjustment disorder with anxiety. The planned comparison Servant and colleagues proposed three randomized groups receiving computer-based stress management, an equivalent face-to-face…

Spread the love

Read Article: How Did a Stress-Management Trial Protocol Handle Medication Changes?

What Evidence Supports Extending Lipid Rescue to a Different Poison?

A treatment that appears useful for one toxicant raises a separate scientific question when proposed for another. Eisenkraft and Falk’s 2016 review of lipid emulsion and chemical-agent poisoning provides an example of that evidence gap. Several evidence types The authors discussed proposed lipid-scavenging, metabolic, and cardiovascular mechanisms. They reviewed laboratory…

Spread the love

Read Article: What Evidence Supports Extending Lipid Rescue to a Different Poison?

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us